Drägerwerk AG & Co. KGaA Logo

Drägerwerk AG & Co. KGaA

0MT8.L

(0.0)
Stock Price

41,30 EUR

4.33% ROA

8.23% ROE

7.85x PER

Market Cap.

870.090.612,00 EUR

18.13% DER

3.7% Yield

3.46% NPM

Drägerwerk AG & Co. KGaA Stock Analysis

Drägerwerk AG & Co. KGaA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Drägerwerk AG & Co. KGaA Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Drägerwerk AG & Co. KGaA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Drägerwerk AG & Co. KGaA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Drägerwerk AG & Co. KGaA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Drägerwerk AG & Co. KGaA Revenue
Year Revenue Growth
2005 0
2006 1.801.300.000 100%
2007 1.819.469.000 1%
2008 1.924.545.000 5.46%
2009 1.911.087.000 -0.7%
2010 2.177.281.000 12.23%
2011 2.255.847.000 3.48%
2012 2.373.495.000 4.96%
2013 2.374.164.000 0.03%
2014 2.434.656.000 2.48%
2015 2.608.920.000 6.68%
2016 2.523.838.000 -3.37%
2017 2.572.256.000 1.88%
2018 2.595.010.000 0.88%
2019 2.780.824.000 6.68%
2020 3.406.276.000 18.36%
2021 3.328.419.000 -2.34%
2022 3.045.227.000 -9.3%
2023 3.154.008.000 3.45%
2023 3.373.504.000 6.51%
2024 3.138.700.000 -7.48%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Drägerwerk AG & Co. KGaA Research and Development Expenses
Year Research and Development Expenses Growth
2005 -108.348.000
2006 117.996.000 191.82%
2007 121.933.000 3.23%
2008 134.903.000 9.61%
2009 149.373.000 9.69%
2010 148.361.000 -0.68%
2011 160.548.000 7.59%
2012 197.338.000 18.64%
2013 201.530.000 2.08%
2014 212.020.000 4.95%
2015 231.097.000 8.25%
2016 219.022.000 -5.51%
2017 234.674.000 6.67%
2018 252.171.000 6.94%
2019 263.707.000 4.37%
2020 289.595.000 8.94%
2021 328.578.000 11.86%
2022 343.482.000 4.34%
2023 325.644.000 -5.48%
2023 319.817.000 -1.82%
2024 334.420.000 4.37%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Drägerwerk AG & Co. KGaA General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 126.380.000 100%
2007 120.591.000 -4.8%
2008 135.592.000 11.06%
2009 96.126.000 -41.06%
2010 117.943.000 18.5%
2011 149.508.000 21.11%
2012 140.235.000 -6.61%
2013 119.972.000 -16.89%
2014 123.972.000 3.23%
2015 250.200.000 50.45%
2016 207.417.000 -20.63%
2017 197.710.000 -4.91%
2018 198.458.000 0.38%
2019 219.428.000 9.56%
2020 248.120.000 11.56%
2021 261.114.000 4.98%
2022 258.659.000 -0.95%
2023 221.892.000 -16.57%
2023 237.919.000 6.74%
2024 256.124.000 7.11%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Drägerwerk AG & Co. KGaA EBITDA
Year EBITDA Growth
2005 1.445.841.000
2006 187.802.000 -669.88%
2007 170.799.000 -9.95%
2008 160.154.000 -6.65%
2009 140.406.000 -14.06%
2010 192.783.000 27.17%
2011 213.777.000 9.82%
2012 238.829.000 10.49%
2013 207.180.000 -15.28%
2014 189.169.000 -9.52%
2015 79.499.000 -137.95%
2016 160.366.000 50.43%
2017 152.715.000 -5.01%
2018 67.023.000 -127.85%
2019 84.272.000 20.47%
2020 411.526.000 79.52%
2021 280.886.000 -46.51%
2022 -73.188.000 483.79%
2023 252.204.000 129.02%
2023 340.618.000 25.96%
2024 199.604.000 -70.65%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Drägerwerk AG & Co. KGaA Gross Profit
Year Gross Profit Growth
2005 846.757.000
2006 871.578.000 2.85%
2007 866.060.000 -0.64%
2008 891.343.000 2.84%
2009 831.725.000 -7.17%
2010 1.044.091.000 20.34%
2011 1.108.340.000 5.8%
2012 1.167.010.000 5.03%
2013 1.147.564.000 -1.69%
2014 1.138.022.000 -0.84%
2015 1.171.670.000 2.87%
2016 1.135.428.000 -3.19%
2017 1.152.160.000 1.45%
2018 1.108.046.000 -3.98%
2019 1.188.419.000 6.76%
2020 1.608.894.000 26.13%
2021 1.540.912.000 -4.41%
2022 1.238.387.000 -24.43%
2023 1.387.380.000 10.74%
2023 1.402.346.000 1.07%
2024 1.391.544.000 -0.78%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Drägerwerk AG & Co. KGaA Net Profit
Year Net Profit Growth
2005 0
2006 43.659.000 100%
2007 46.148.000 5.39%
2008 32.507.000 -41.96%
2009 14.906.000 -118.08%
2010 104.783.000 85.77%
2011 120.711.000 13.2%
2012 138.355.000 12.75%
2013 120.458.000 -14.86%
2014 104.561.000 -15.2%
2015 33.001.000 -216.84%
2016 82.081.000 59.79%
2017 98.470.000 16.64%
2018 34.355.000 -186.62%
2019 33.350.000 -3.01%
2020 188.588.000 82.32%
2021 154.231.000 -22.28%
2022 -63.637.000 342.36%
2023 70.492.000 190.28%
2023 110.433.000 36.17%
2024 106.544.000 -3.65%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Drägerwerk AG & Co. KGaA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 3 100%
2007 4 0%
2008 2 -50%
2009 1 -100%
2010 6 83.33%
2011 7 14.29%
2012 8 0%
2013 7 -16.67%
2014 6 -20%
2015 1 -400%
2016 3 66.67%
2017 4 25%
2018 2 -300%
2019 1 0%
2020 10 90%
2021 7 -42.86%
2022 -3 333.33%
2023 0 0%
2023 6 100%
2024 6 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Drägerwerk AG & Co. KGaA Free Cashflow
Year Free Cashflow Growth
2005 30.165.000
2006 6.870.000 -339.08%
2007 29.210.000 76.48%
2008 22.075.000 -32.32%
2009 141.991.000 84.45%
2010 162.781.000 12.77%
2011 89.188.000 -82.51%
2012 107.768.000 17.24%
2013 -23.053.000 567.48%
2014 82.104.000 128.08%
2015 -74.528.000 210.17%
2016 115.562.000 164.49%
2017 72.611.000 -59.15%
2018 -57.636.000 225.98%
2019 100.030.000 157.62%
2020 345.040.000 71.01%
2021 274.544.000 -25.68%
2022 -231.087.000 218.81%
2023 121.468.000 290.25%
2023 42.257.000 -187.45%
2024 -52.047.000 181.19%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Drägerwerk AG & Co. KGaA Operating Cashflow
Year Operating Cashflow Growth
2005 30.165.000
2006 89.207.000 66.19%
2007 157.747.000 43.45%
2008 97.470.000 -61.84%
2009 193.452.000 49.62%
2010 219.141.000 11.72%
2011 159.906.000 -37.04%
2012 176.754.000 9.53%
2013 68.341.000 -158.64%
2014 187.982.000 63.64%
2015 39.861.000 -371.59%
2016 195.322.000 79.59%
2017 143.336.000 -36.27%
2018 4.090.000 -3404.55%
2019 164.420.000 97.51%
2020 459.980.000 64.25%
2021 384.886.000 -19.51%
2022 -144.228.000 366.86%
2023 189.677.000 176.04%
2023 54.105.000 -250.57%
2024 -39.025.000 238.64%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Drägerwerk AG & Co. KGaA Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 82.337.000 100%
2007 128.537.000 35.94%
2008 75.395.000 -70.48%
2009 51.461.000 -46.51%
2010 56.360.000 8.69%
2011 70.718.000 20.3%
2012 68.986.000 -2.51%
2013 91.394.000 24.52%
2014 105.878.000 13.68%
2015 114.389.000 7.44%
2016 79.760.000 -43.42%
2017 70.725.000 -12.77%
2018 61.726.000 -14.58%
2019 64.390.000 4.14%
2020 114.940.000 43.98%
2021 110.342.000 -4.17%
2022 86.859.000 -27.04%
2023 68.209.000 -27.34%
2023 11.848.000 -475.7%
2024 13.022.000 9.02%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Drägerwerk AG & Co. KGaA Equity
Year Equity Growth
2005 257.679.000
2006 539.990.000 52.28%
2007 505.488.000 -6.83%
2008 517.641.000 2.35%
2009 393.820.000 -31.44%
2010 636.563.000 38.13%
2011 729.616.000 12.75%
2012 727.201.000 -0.33%
2013 815.967.000 10.88%
2014 896.606.000 8.99%
2015 945.930.000 5.21%
2016 1.003.516.000 5.74%
2017 1.068.344.000 6.07%
2018 1.080.660.000 1.14%
2019 1.076.359.000 -0.4%
2020 1.033.811.000 -4.12%
2021 1.260.495.000 17.98%
2022 1.319.431.000 4.47%
2023 1.382.107.000 4.53%
2023 1.409.235.000 1.93%
2024 1.442.040.000 2.27%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Drägerwerk AG & Co. KGaA Assets
Year Assets Growth
2005 1.536.237.056
2006 1.636.258.000 6.11%
2007 1.637.500.000 0.08%
2008 1.654.777.000 1.04%
2009 1.885.828.000 12.25%
2010 1.976.907.000 4.61%
2011 2.115.189.000 6.54%
2012 2.101.205.000 -0.67%
2013 2.065.011.000 -1.75%
2014 2.234.110.000 7.57%
2015 2.311.397.000 3.34%
2016 2.312.325.000 0.04%
2017 2.354.366.000 1.79%
2018 2.410.227.000 2.32%
2019 2.570.910.000 6.25%
2020 3.305.992.000 22.23%
2021 3.178.263.000 -4.02%
2022 3.106.576.000 -2.31%
2023 3.001.571.000 -3.5%
2023 3.256.363.000 7.82%
2024 3.031.215.000 -7.43%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Drägerwerk AG & Co. KGaA Liabilities
Year Liabilities Growth
2005 1.278.558.056
2006 1.096.268.000 -16.63%
2007 1.132.012.000 3.16%
2008 1.137.136.000 0.45%
2009 1.492.008.000 23.78%
2010 1.340.344.000 -11.32%
2011 1.385.573.000 3.26%
2012 1.374.004.000 -0.84%
2013 1.249.044.000 -10%
2014 1.337.504.000 6.61%
2015 1.365.467.000 2.05%
2016 1.308.809.000 -4.33%
2017 1.286.022.000 -1.77%
2018 1.329.567.000 3.28%
2019 1.494.551.000 11.04%
2020 2.272.181.000 34.22%
2021 1.917.768.000 -18.48%
2022 1.787.145.000 -7.31%
2023 1.619.464.000 -10.35%
2023 1.847.128.000 12.33%
2024 1.589.176.000 -16.23%

Drägerwerk AG & Co. KGaA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
179.19
Net Income per Share
6.2
Price to Earning Ratio
7.85x
Price To Sales Ratio
0.26x
POCF Ratio
4.77
PFCF Ratio
6.49
Price to Book Ratio
0.63
EV to Sales
0.3
EV Over EBITDA
3.68
EV to Operating CashFlow
5.34
EV to FreeCashFlow
7.62
Earnings Yield
0.13
FreeCashFlow Yield
0.15
Market Cap
0,87 Bil.
Enterprise Value
1,02 Bil.
Graham Number
103.53
Graham NetNet
-21.3

Income Statement Metrics

Net Income per Share
6.2
Income Quality
1.63
ROE
0.08
Return On Assets
0.04
Return On Capital Employed
0.09
Net Income per EBT
0.75
EBT Per Ebit
0.81
Ebit per Revenue
0.06
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0.1
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.44
Operating Profit Margin
0.06
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0.04
Dividend Yield %
3.7
Payout Ratio
0.28
Dividend Per Share
1.8

Operating Metrics

Operating Cashflow per Share
10.21
Free CashFlow per Share
7.15
Capex to Operating CashFlow
0.3
Capex to Revenue
0.02
Capex to Depreciation
0.4
Return on Invested Capital
0.08
Return on Tangible Assets
0.04
Days Sales Outstanding
87.44
Days Payables Outstanding
37.53
Days of Inventory on Hand
138.91
Receivables Turnover
4.17
Payables Turnover
9.73
Inventory Turnover
2.63
Capex per Share
3.06

Balance Sheet

Cash per Share
11,99
Book Value per Share
76,87
Tangible Book Value per Share
58.52
Shareholders Equity per Share
76.78
Interest Debt per Share
15.31
Debt to Equity
0.18
Debt to Assets
0.09
Net Debt to EBITDA
0.55
Current Ratio
1.88
Tangible Asset Value
1,10 Bil.
Net Current Asset Value
0,22 Bil.
Invested Capital
1746426000
Working Capital
0,84 Bil.
Intangibles to Total Assets
0.11
Average Receivables
0,79 Bil.
Average Payables
0,19 Bil.
Average Inventory
714085000
Debt to Market Cap
0.3

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Drägerwerk AG & Co. KGaA Dividends
Year Dividends Growth
2011 1
2012 0 0%
2013 1 0%
2014 1 0%
2015 1 100%
2016 0 0%
2017 0 0%
2023 0 0%
2024 2 100%

Drägerwerk AG & Co. KGaA Profile

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.

CEO
Mr. Stefan A. Drager B.A.
Employee
16.390
Address
Moislinger Allee 53-55
Lübeck, 23558

Drägerwerk AG & Co. KGaA Executives & BODs

Drägerwerk AG & Co. KGaA Executives & BODs
# Name Age
1 Mr. Welf Böttcher
Head of Corporate Communications
70
2 Mr. Gert-Hartwig Lescow
Chief Financial Officer, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG
70
3 Thomas Fischler
Head of Treasury & Investor Relations
70
4 Mr. Anton Schrofner
Executive Board Member for Medical Division - Drägerwerk Verwaltungs AG
70
5 Mr. Rainer Klug
Executive Board Member for Safety Division - Drägerwerk Verwaltungs AG
70
6 Mr. Stefan A. Drager B.A.
Chairman of the Executive Board - Drägerwerk Verwaltungs AG
70
7 Dr. Reiner Piske
Executive Board Member for Sales & Human Resources - Drägerwerk Verwaltungs AG
70

Drägerwerk AG & Co. KGaA Competitors